GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » NorthStar Healthcare Income Inc (OTCPK:NHHS) » Definitions » EBITDA

NorthStar Healthcareome (NorthStar Healthcareome) EBITDA : $-64.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is NorthStar Healthcareome EBITDA?

NorthStar Healthcareome's EBITDA for the three months ended in Mar. 2024 was $13.7 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-64.9 Mil.

During the past 12 months, the average EBITDA Growth Rate of NorthStar Healthcareome was -338.80% per year. During the past 3 years, the average EBITDA Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 11 years, the highest 3-Year average EBITDA Growth Rate of NorthStar Healthcareome was 78.00% per year. The lowest was -23.90% per year. And the median was 10.75% per year.

NorthStar Healthcareome's EBITDA per Share for the three months ended in Mar. 2024 was $0.07. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.34.

During the past 12 months, the average EBITDA per Share Growth Rate of NorthStar Healthcareome was -341.80% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 11 years, the highest 3-Year average EBITDA per Share Growth Rate of NorthStar Healthcareome was 78.20% per year. The lowest was -24.60% per year. And the median was 47.65% per year.


NorthStar Healthcareome EBITDA Historical Data

The historical data trend for NorthStar Healthcareome's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NorthStar Healthcareome EBITDA Chart

NorthStar Healthcareome Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.21 -133.19 143.37 27.43 -71.64

NorthStar Healthcareome Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.03 -37.66 12.73 -53.73 13.74

Competitive Comparison of NorthStar Healthcareome's EBITDA

For the REIT - Healthcare Facilities subindustry, NorthStar Healthcareome's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NorthStar Healthcareome's EV-to-EBITDA Distribution in the REITs Industry

For the REITs industry and Real Estate sector, NorthStar Healthcareome's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where NorthStar Healthcareome's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

NorthStar Healthcareome's EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

NorthStar Healthcareome's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2023, NorthStar Healthcareome's EBITDA was $-71.6 Mil.

NorthStar Healthcareome's EBITDA for the quarter that ended in Mar. 2024 is calculated as

NorthStar Healthcareome's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2024, NorthStar Healthcareome's EBITDA was $13.7 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-64.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

NorthStar Healthcareome  (OTCPK:NHHS) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


NorthStar Healthcareome EBITDA Related Terms

Thank you for viewing the detailed overview of NorthStar Healthcareome's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


NorthStar Healthcareome (NorthStar Healthcareome) Business Description

Traded in Other Exchanges
N/A
Address
16 East 34th Street, 18th Floor, New York, NY, USA, 10016
NorthStar Healthcare Income Inc is a real estate investment trust. The trust is formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, such as assisted living, memory care, skilled nursing and independent living facilities and continuing care retirement communities. It also invests in other healthcare property types, including medical office buildings, hospitals, rehabilitation facilities and ancillary healthcare services businesses. The trust operates in five segments namely Direct Investments - Net Lease; Direct Investments - Operating; Unconsolidated Investments; Debt and Securities Investments; and Corporate.
Executives
Ann Harrington officer: General Counsel and Secretary C/O COLONY NORTHSTAR, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Kendall K Young officer: CEO and President 3760 KILROY AIRPORT WAY, SUITE 300, LONG BEACH CA 90806
Nicholas Balzo officer: Chief Financial Officer 201 COMMONS PARK S, UNIT 502, STAMFORD CT 06902
Paul Varisano officer: Chief Financial Officer 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Neale Redington officer: Chief Financial Officer C/O COLONY NORTHSTAR, INC., 515 S. FLOWER ST., 44TH FLOOR, LOS ANGELES CA 90071
Jonathan A. Carnella director C/O NORTHSTAR HEALTHCARE INCOME, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Richard S. Welch director, officer: Chairman C/O COLONY NORTHSTAR, INC., 515 S. FLOWER STREET, LOS ANGELES CA 90071
Smith Jack Fleming Jr. director C/O NORTHSTAR REALTY FINANCE CORP., 399 PARK AVENUE, 18TH FLOOR, NEW YORK NY 10022
Gregory A Samay director C/O NORTHSTAR HEALTHCARE INCOME INC, 399 PARK AVE 18TH FLOOR, NEW YORK NY 10022
Thomas Andrew Smith director 111 WESTWOOD PLACE, SUITE 400, BRENTWOOD TN 37027
Justin T Chang director, officer: Chairman 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Daniel Joseph Altobello director 6550 ROCK SPRING DR, SUITE 550, BETHESDA MD 20817
Robert C Gatenio director, officer: Vice Chairman C/O COLONY NORTHSTAR, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Frank V Saracino officer: CFO and Treasurer 399 PARK AVENUE, 18TH FLOOR, NEW YORK NY 10022
Ronald J Jeanneault officer: CEO and President C/O NORTHSTAR HEALTHCARE INCOME, INC., 399 PARK AVENUE, 18TH FL, NEW YORK NY 10022

NorthStar Healthcareome (NorthStar Healthcareome) Headlines

No Headlines